Evidence map›Paper›PMID 36455555›Full record

ArticleCell reports. Medicine2022

Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.

William S Foster, Jia Le Lee, Nazia Thakur, Joseph Newman, Alexandra J Spencer, Sophie Davies, Danielle Woods, Leila Godfrey, Iain M Hay, Silvia Innocentin and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports. Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 22 citations in OpenAlex.

  1. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Distinct Requirements for CD4European journal of immunology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

William S FosterLymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
Jia Le LeeLymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
Nazia ThakurThe Pirbright Institute, Ash Road, Pirbright GU24 0NF, UK; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford and Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), Oxford OX3 7BN, UK.
Joseph NewmanThe Pirbright Institute, Ash Road, Pirbright GU24 0NF, UK.
Alexandra J SpencerThe Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.
Sophie DaviesOxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford and Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), Oxford OX3 7BN, UK.
Danielle WoodsThe Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.
Leila GodfreyThe Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.
Iain M HaySignalling Programme, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK; Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 0XY, UK.
Silvia InnocentinLymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
Juan Carlos Yam-PucMRC Toxicology Unit, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.
Emily C HornerMRC Toxicology Unit, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.
Hayley J SharpeSignalling Programme, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
James E ThaventhiranMRC Toxicology Unit, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.
Dalan BaileyThe Pirbright Institute, Ash Road, Pirbright GU24 0NF, UK.
Teresa LambeOxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford and Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), Oxford OX3 7BN, UK. Electronic address: teresa.lambe@paediatrics.ox.ac.uk.
Michelle A LintermanLymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK. Electronic address: michelle.linterman@babraham.ac.uk.
Babraham Institute · GBUniversity of Oxford · GBMRC Toxicology Unit · GBThe Pirbright Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/COV07001Biotechnology and Biological Sciences Research Council BB/T008784/1Medical Research Council MC_UU_0025/12Medical Research Council MR/W005611/1MRF_ MRF-057-0002-RG-THAV-C0798Wellcome Trust
6 · The paper itself

Abstract

Emergence from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been facilitated by the rollout of effective vaccines. Successful vaccines generate high-affinity plasma blasts and long-lived protective memory B cells. Here, we show a requirement for T follicular helper (Tfh) cells and the germinal center reaction for optimal serum antibody and memory B cell formation after ChAdOx1 nCoV-19 vaccination. We found that Tfh cells play an important role in expanding antigen-specific B cells while identifying Tfh-cell-dependent and -independent memory B cell subsets. Upon secondary vaccination, germinal center B cells generated during primary immunizations can be recalled as germinal center B cells again. Likewise, primary immunization GC-Tfh cells can be recalled as either Tfh or Th1 cells, highlighting the pluripotent nature of Tfh cell memory. This study demonstrates that ChAdOx1 nCoV-19-induced germinal centers are a critical source of humoral immunity.

Indexed as

COVID-19Immunity, HumoralChAdOx1 nCoV-19Germinal CenterHumansImmunization, SecondaryMemory B CellsSARS-CoV-2T Follicular Helper CellsT-Lymphocytes, Helper-InducerVaccinationChAdOx1 nCoV-19CD40LChAdOx1 nCoV-19germinal centerSARS-CoV-2Tfh cellsvaccine

Identifiers

PMID36455555
PMCPMC9663747
OpenAlexW4309338764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.